Vanguard Portfolio Management’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$552K Buy
23,417
+5,287
+29% +$109K ﹤0.01% 3048
2026
Q1
$311K Buy
+18,130
New +$373K ﹤0.01% 3008

Other funds holding SMTI

Vanguard Portfolio Management's SMTI Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Sanara MedTech (SMTI) stake by 29% in Q2 2026, buying an estimated $109K and bringing the position to 23,417 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #3048.

Vanguard Portfolio Management first reported a position in SMTI in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Vanguard Portfolio Management held 23,417 shares of Sanara MedTech worth $552K as of Q2 2026.
  • Vanguard Portfolio Management bought 5,287 Sanara MedTech shares in Q2 2026, an estimated $109K.
  • Sanara MedTech made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3048 holding.
  • Vanguard Portfolio Management first reported a position in Sanara MedTech in Q1 2026 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.